SOURCE: Exosome Diagnostics

Exosome Diagnostics

November 29, 2016 07:30 ET

Exosome Diagnostics to Participate in Evercore ISI MedTools 2016 Investor Conference

CAMBRIDGE, MA--(Marketwired - November 29, 2016) - Exosome Diagnostics, Inc. announced today that John Boyce, President and Chief Executive Officer and the senior management team will be participating in the annual Evercore MedTools Conference being held in Boston on November 30 and December 1, 2016 to meet with potential investors, crossover funds, and strategic partners. Due to the one-on-one investor meeting format of the event, no webcast will be available.

About Exosome Diagnostics

Exosome Diagnostics is a privately held company focused on developing and commercializing revolutionary biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. The company's novel exosome-based technology platform, ExoLution™, can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are diagnosed, treated and monitored. Visit www.exosomedx.com to learn more.

ExoDx is a registered trademark of Exosome Diagnostics, Inc. Exosome Diagnostics and ExoLution are unregistered trademarks of Exosome Diagnostics, Inc.

Contact Information